ESC 365 - Hitting LDL-C goals in high- and very high-risk patients: why oral combination therapy matters

Open Access

Hitting LDL-C goals in high- and very high-risk patients: why oral combination therapy matters

Session: Breaking barriers in LDL-C management: the power of oral combination therapy

Topic: Drug therapy

Speaker: Doctor D. Andreini (Milan, IT)

Sponsored by Daiichi Sankyo Europe GmbH

Event: ESC Preventive Cardiology 2025

Congress Presentation

Add to my library

About the speaker

Doctor Daniele Andreini

Galeazzi-Sant'Ambrogio Hospital IRCCS, Milan (Italy)

7 presentations

0 follower

4 more presentations in this session

Welcome and introduction

Speaker: Professor S. Brouwers (Aalst, BE) Associate Professor R. Pedretti (Milan, IT)

How Bempedoic acid fits into oral combinations: unique mechanism and clinical impact

Speaker: Professor G. Norata (Milan, IT)

Boost adherence, reduce risk: practical strategies for integrating combination therapy

Speaker: Professor M. Muiesan (Brescia, IT)

Panel discussion, Q&A and closing remarks

Speaker: Associate Professor R. Pedretti (Milan, IT) Professor S. Brouwers (Aalst, BE)

Access the full session

Breaking barriers in LDL-C management: the power of oral combination therapy

Speakers: Doctor D. Andreini, Professor S. Brouwers, Associate Professor R. Pedretti, Professor G. Norata, Professor M. Muiesan...

About the event

ESC Preventive Cardiology 2025

3 April - 5 April 2025

Sessions Presentations

Congress

ESC 365 is supported by

novartis

Explore sponsored resources